Description
49,800 equity shares of Trident Lifeline Limited issued at premium to promoters on preferential basis pursuant to warrant conversion, listed and permitted to trade from January 9, 2026.
Summary
BSE has listed 49,800 new equity shares of Trident Lifeline Limited (Scrip Code: 543616) issued to promoters on a preferential basis pursuant to conversion of warrants. The shares are permitted to trade on the exchange with effect from Friday, January 9, 2026. The shares were allotted at Rs. 266 per share (face value Rs. 10 plus premium of Rs. 256) and are subject to lock-in until July 30, 2027.
Key Points
- 49,800 equity shares of Rs. 10/- each issued at a premium of Rs. 256/-
- Issued to promoters on preferential basis pursuant to warrant conversion
- Shares rank pari-passu with existing equity shares
- Distinctive Numbers: 11592201 to 11642000
- Date of Allotment: November 21, 2025
- Issue Price: Rs. 266 per share
- ISIN: INE0MKA01014
- Complete lock-in on all 49,800 shares until July 30, 2027
Regulatory Changes
No regulatory changes introduced by this circular.
Compliance Requirements
Trading members are informed of the listing of new securities. No specific compliance actions required from market participants. The promoter allottees must comply with the lock-in requirements until July 30, 2027.
Important Dates
- Date of Allotment: November 21, 2025
- Trading Commencement Date: Friday, January 9, 2026
- Lock-in Expiry Date: July 30, 2027
Impact Assessment
Minimal market impact as this is a small preferential allotment of 49,800 shares to promoters. The shares are subject to lock-in for approximately 18 months, preventing immediate trading by allottees. This represents a routine corporate action with no material effect on market operations or liquidity. The warrant conversion indicates promoter confidence and capital infusion into the company.
Impact Justification
Routine listing of small preferential allotment to promoters (49,800 shares) with no impact on general trading or compliance requirements for market participants.